From Volatility to Value: A Framework for Healthcare Supply Chain Strategy in 2026
The forces reshaping healthcare supply chains this year are permanent, and the health systems that treat them that way will pull ahead.
Supply chain management has never been a simple discipline. But the convergence of forces now shaping the healthcare landscape, regulatory upheaval, tariff instability, persistent inflation, and accelerating care migration, has elevated it to a strategic imperative at the executive level. For health system leaders, the question is no longer whether supply chain deserves a seat at the leadership table. The question is how quickly that seat can be secured and how effectively it can be used.
This post examines the environment bearing down on healthcare supply chains today, outlines the strategies most likely to produce durable improvement, and offers a framework for thinking about what's next in 2026 and beyond.
Why Supply Chain Deserves Executive Attention
The scope of supply chain extends far beyond medical-surgical and pharmaceutical supplies, which typically represent 11 to 22 percent of a health system's total cost. When purchased services, food, contract labor, and information technology are included, supply-related expenditures can account for approximately 48 percent of operating costs, according to Definitive Healthcare's HospitalView data. Add capital and medical equipment, and that figure can approach 50 percent.
What makes supply chain particularly attractive as a margin lever is the near-direct translation of savings to the bottom line. When contracts are executed and costs are reduced, those savings aren't diluted by overhead allocation. They land on the income statement. In an era when most health systems are being asked to do more with less, that characteristic alone justifies significant executive investment, and it's exactly where our supply chain and purchased services work tends to find the most immediate wins.
The Environment in 2026: What's Driving the Pressure
Regulatory and coverage shifts. The One Big Beautiful Bill Act, signed into law in July 2025, introduced sweeping changes to Medicaid and ACA marketplace coverage, including new work requirements for Medicaid expansion enrollees, more frequent eligibility redeterminations, and the expiration of enhanced premium tax credits at the end of 2025.
The Congressional Budget Office projects these provisions will result in approximately 10 million additional uninsured Americans by 2034, with near-term coverage losses beginning in 2026. These losses are already beginning to reshape patient acuity and care settings. Health systems should expect to absorb a growing volume of patients with complex, chronic conditions as coverage gaps widen.
The same legislation established the Rural Health Transformation Program, a five-year, $50 billion federal initiative, with awards distributed to all 50 states beginning in December 2025. How those resources flow into rural care delivery remains uncertain, but the program signals a structural shift in how care will be organized and financed across a significant share of the country's geography.
Geopolitical risk and tariff volatility. Supply chain professionals have long understood that the materials entering a hospital come from a global manufacturing base, but the degree of exposure to international disruption has become more acute. An estimated 62 percent of medical devices used in the United States are imported, and nearly 70 percent of US-marketed devices are manufactured solely outside the country, making sweeping tariff regimes particularly burdensome for healthcare providers.
Add to this the recent instability with shipping in and around the Strait of Hormuz, which has disrupted the resin market and glove production in Malaysia, source of 45 percent of the world's supply, and the vulnerabilities compound quickly.
Tariff instability compounds this risk further. During the current period of trade uncertainty, some suppliers have been unable to establish pricing due to the layered complexity of variable tariff schedules, material assembly timing, and shifting country-of-origin rules. Health systems that haven't built tariff pass-through protections and hard escalation ceilings into their contracts are particularly exposed. The best protection is to build these terms into your contracts before you need them, not after.
Cybersecurity as a supply chain risk. Healthcare's cybersecurity vulnerabilities are well documented, but supply chain leaders must now account for risks that originate not within their own systems but within their supplier networks. In March 2026, a cyberattack on major medical device manufacturer Stryker disrupted order processing, manufacturing, and shipping operations globally, causing some health systems to delay surgical procedures. A supply chain strategy that doesn't include supplier cyber-risk assessment is incomplete.
Care migration and expanding footprint. The continued shift of care to non-acute settings, ambulatory surgery centers, hospital-at-home programs, outpatient facilities, means supply chain management must extend beyond the four walls of the acute care hospital.
Sg2's 2025 Impact of Change Forecast projects 18 percent growth in adult outpatient volumes over the next decade, compared to only 5 percent growth in adult inpatient discharges. Contracts and distribution systems designed for the inpatient environment don't automatically translate to non-acute settings. Health systems that haven't yet extended supply chain governance to their full care continuum face both cost and compliance risk.
Projected cost increases. Despite widespread pressure to reduce expenditures, supply costs are predicted to continue rising across all major categories in 2026. Drug costs are projected to increase by more than 3 percent overall, with non-contract pharmaceutical products rising nearly 4 percent. Medical-surgical products are expected to increase approximately 2 percent on average, with surgical supplies increasing at a higher rate, according to Provista's industry pricing analysis. Purchased services and information technology, increasingly the fastest-growing cost categories, are experiencing persistent inflation that, in some categories, may exceed these projections.
A Framework for Managing What's Controllable
Leaders who absorb the scope of these pressures sometimes find themselves paralyzed by the scale of the challenge. A more productive posture starts with a clear distinction between what's controllable and what isn't, paired with a commitment to executing aggressively on the former. We've covered the tactical playbook for most of this in depth elsewhere, so here's the short version, with pointers to where you can go deeper.
Supply disruptions are no longer episodic events to manage reactively. They're a permanent feature of the operating environment, and health systems that build standing infrastructure, a formal disruption team, resiliency dashboards that provide executive-level visibility, dual sourcing for critical categories, pre-approved substitution protocols, before the next shortage hits will be far better positioned than those that improvise a response every time. We walk through that playbook step by step here.
Contracting deserves the same shift in thinking. Unit price is one data point. Total delivered cost, inclusive of freight, fuel surcharges, and inventory carrying costs, and increasingly, value-based agreements built around outcomes and supply assurance rather than volume alone, is what actually protects your margin. The same applies to your GPO relationship: it's a tool, not a strategy, and treating it as a default pricing mechanism leaves value on the table. We break down how to build a deliberate contracting and GPO strategy here.
Value analysis and purchased services governance round out the picture. The traditional value analysis committee, built for long meeting cycles and broad membership, is too slow for the pace of disruption supply chain teams face today. And purchased services, often managed in silos with no central visibility, remain one of the largest untapped margin opportunities in most health systems. Here's how we help organizations modernize both.
The one area the playbook hasn't covered yet: treat AI governance as a prerequisite, not a follow-on step. AI applications are already embedded in the supply chain workflows of the major ERP platforms, including Workday, Oracle, Infor, and GHX. Touchless purchase order processing, automated contract and price validation, and intelligent invoice matching are available today and are generating measurable efficiency gains for health systems that have deployed them.
According to GHX, AI tools are now capable of analyzing complex supply chain patterns, flagging potential risks, and suggesting alternatives to maintain continuity, functions that were largely manual just a few years ago. What's coming next is more significant: enterprise data ecosystems that enable cross-organizational forecasting, AI agents built specifically for supply chain functions and customized to individual organizations, and predictive tools that can identify disruption risk earlier than human monitoring currently allows.
The right response isn't to defer adoption until the technology matures further. It's to build the governance infrastructure of ethics policies, training protocols, and data management frameworks that will let your organization adopt AI responsibly and at pace. If your ERP roadmap doesn't yet account for this, our ERP Supply Chain team at Acuvance ROI can help you build that governance into the platform itself, not bolt it on afterward. Organizations that haven't yet established AI governance are likely to find themselves behind their suppliers, who are deploying these tools aggressively. A health system that can't evaluate, adopt, and govern AI applications will increasingly negotiate from a position of information disadvantage.
What Health System Leaders Should Do Now
The supply chain environment of 2026 rewards organizations that invest in governance, data, and cross-functional integration, and penalizes those that treat supply chain as a procurement function rather than a strategic capability.
Leaders should ensure supply chain has direct representation in executive and board-level discussions of financial performance, margin improvement, and capital strategy. They should invest in the analytical infrastructure, spend analytics, contract management systems, service line analytics, and benchmarking tools, that supply chain teams need to identify opportunities and track performance. They should conduct a comprehensive portfolio audit covering GPO contracts, direct contracts, and purchased services, to understand where value is being captured and where it's being lost. And they should build people and process capabilities by leveraging nurse advisors, physician champions, skilled negotiators, and financial analysts to translate good contracting into sustained margin improvement.
Supply chain isn't a support function. In the current environment, it's one of the most consequential leverage points available to health system leadership. At Acuvance Coker, we help health systems build exactly this kind of capability, and we welcome the chance to talk through where your organization stands today.
